David B Menkes
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 2%
- Stress Responses and Cortisol
Papers in
-
- Psychedelics and Drug Studies 11
-
- Schizophrenia research and treatment 15
- Electroconvulsive Therapy Studies 8
- Co-authors
- George K. Aghajanian (6 shared papers)Mark A. Geyer (2 shared papers)Arnold J. Mandell (2 shared papers)J. Paul Fawcett (3 shared papers)Amadeo Puerto (1 shared paper)David S. Segal (1 shared paper)Dorothy W. Gallager (3 shared papers)G. F. S. Spears (4 shared papers)
- Journals
- Australian & New Zealand Journal of Psychiatry (7 papers)International Clinical Psychopharmacology (4 papers)Neuropharmacology (3 papers)Trials (3 papers)Environmental Health Perspectives (3 papers)
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
David B Menkes
114 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 149
- Biological Psychiatry 210
- Behavioral Neuroscience 188
- Cellular and Molecular Neuroscience 839
- Psychiatry and Mental health 695
- Pharmacology 487
Countries citing papers authored by David B Menkes
This map shows the geographic impact of David B Menkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B Menkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B Menkes more than expected).
Fields of papers citing papers by David B Menkes
This network shows the impact of papers produced by David B Menkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B Menkes. The network helps show where David B Menkes may publish in the future.
Co-authors
The 25 scholars most cited alongside David B Menkes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 270 | |
| 2 | 2004 | 210 | |
| 3 | 1994 | 142 | |
| 4 | 2016 | 123 | |
| 5 | 1983 | 117 | |
| 6 | 1980 | 115 | |
| 7 | 1981 | 111 | |
| 8 | 1981 | 105 | |
| 9 | 1980 | 102 | |
| 10 | 1991 | 98 | |
| 11 | 1983 | 92 | |
| 12 | 1992 | 80 | |
| 13 | 2013 | 79 | |
| 14 | 1993 | 62 | |
| 15 | 1991 | 60 | |
| 16 | 2006 | 57 | |
| 17 | 2012 | 53 | |
| 18 | 2000 | 48 | |
| 19 | 1991 | 46 | |
| 20 | 1983 | 45 |
About David B Menkes
David B Menkes is a scholar working on Clinical Psychology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health and Pharmacology, having authored 121 papers that have together received 3.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (15 papers), Neurotransmitter Receptor Influence on Behavior (14 papers), Pharmaceutical industry and healthcare (13 papers), Pharmaceutical Economics and Policy (12 papers), Psychedelics and Drug Studies (11 papers), Electroconvulsive Therapy Studies (8 papers), Treatment of Major Depression (8 papers) and Mental Health and Psychiatry (7 papers). The work is most often cited by research in Biological Psychiatry (210 citations), Behavioral Neuroscience (188 citations), Cellular and Molecular Neuroscience (839 citations), Psychiatry and Mental health (695 citations) and Pharmacology (487 citations). David B Menkes has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include George K. Aghajanian, Mark A. Geyer, Arnold J. Mandell, J. Paul Fawcett, Amadeo Puerto, David S. Segal, Dorothy W. Gallager, G. F. S. Spears, Frederick Sundram and William K. Diprose. Their work appears in journals such as Australian & New Zealand Journal of Psychiatry, International Clinical Psychopharmacology, Neuropharmacology, Trials and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.